PKP2 and arrhythmogenic right ventricular cardiomyopathy: Table 4 demonstrated detailed information of these patients. The immunoreactivities of αT-catenin and plakophilin-2 significantly decreased in the ARVC group compared with the non-ARVC group (p = 0.028, Figure 2a,b).